Commercially available glutenases: a potential hazard in coeliac disease
Background: The only treatment for celiac disease (CD) is a gluten-free diet (GFD). However, there is interest among patients in a medical therapy to replace or help with a GFD. Therapies include gluten-degrading enzymes (glutenases). There are glutenases available marketed as dietary supplements th...
Kaydedildi:
| Asıl Yazarlar: | , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
SAGE Publishing
2017-06-01
|
| Seri Bilgileri: | Therapeutic Advances in Gastroenterology |
| Online Erişim: | https://doi.org/10.1177/1756283X17690991 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|